Anifrolumab - AstraZeneca
At a glance
- Drug Originator Medarex
- Drug Licenced by AstraZeneca
- Drug Class Anti-inflammatories; Antirheumatics; Monoclonal antibodies; Skin disorder therapies; Urologics
- Mechanism of Action Interferon alpha beta receptor antagonists
- USA Patent Applicants ASTRAZENECA AB
- USA Patents 6
- BLAs 1
- International Patents 70
Disclaimer